ESR1 and triple-negative breast carcinoma: To determine if activation of p-mTOR occurred in breast cancer subtypes without ER, we next evaluated protein phosphorylation post exposure to FSS in the triple negative breast cancer (TNBC) cell line MDA-MB-231.